Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Cohypermethylation of p14 in combination with CADM1 or DCC as a recurrence-related prognostic indicator in stage I esophageal squamous cell carcinoma.

Lee E, Lee BB, Ko E, Kim Y, Han J, Shim YM, Park J, Kim DH.

Cancer. 2013 May 1;119(9):1752-60. doi: 10.1002/cncr.27948. Epub 2013 Jan 10.

2.

Aberrant methylation of the CADM1 promoter is associated with poor prognosis in hepatocellular carcinoma treated with liver transplantation.

Zhang W, Zhou L, Ding SM, Xie HY, Xu X, Wu J, Chen QX, Zhang F, Wei BJ, Eldin AT, Zheng SS.

Oncol Rep. 2011 Apr;25(4):1053-62. doi: 10.3892/or.2011.1159. Epub 2011 Jan 24.

PMID:
21271221
3.

Hypermethylation of E-cadherin, p16, p14, and RASSF1A genes in pathologically normal urothelium predict bladder recurrence of bladder cancer after transurethral resection.

Lin HH, Ke HL, Wu WJ, Lee YH, Chang LL.

Urol Oncol. 2012 Mar-Apr;30(2):177-81. doi: 10.1016/j.urolonc.2010.01.002. Epub 2010 Aug 25.

PMID:
20800513
4.

Detection of multiple gene hypermethylation in the development of esophageal squamous cell carcinoma.

Nie Y, Liao J, Zhao X, Song Y, Yang GY, Wang LD, Yang CS.

Carcinogenesis. 2002 Oct;23(10):1713-20.

PMID:
12376481
5.

DCC promoter hypermethylation in esophageal squamous cell carcinoma.

Park HL, Kim MS, Yamashita K, Westra W, Carvalho AL, Lee J, Jiang WW, Baek JH, Liu J, Osada M, Moon CS, Califano JA, Mori M, Sidransky D.

Int J Cancer. 2008 Jun 1;122(11):2498-502. doi: 10.1002/ijc.23434.

6.

CpG island hypermethylation of E-cadherin (CDH1) and integrin alpha4 is associated with recurrence of early stage esophageal squamous cell carcinoma.

Lee EJ, Lee BB, Han J, Cho EY, Shim YM, Park J, Kim DH.

Int J Cancer. 2008 Nov 1;123(9):2073-9. doi: 10.1002/ijc.23598.

7.

Association of RASSF1A and p63 with poor recurrence-free survival in node-negative stage I-II non-small cell lung cancer.

Ko E, Lee BB, Kim Y, Lee EJ, Cho EY, Han J, Shim YM, Park J, Kim DH.

Clin Cancer Res. 2013 Mar 1;19(5):1204-12. doi: 10.1158/1078-0432.CCR-12-2848. Epub 2013 Jan 14.

8.

Promoter hypermethylation and quantitative expression analysis of CDKN2A (p14ARF and p16INK4a) gene in esophageal squamous cell carcinoma.

Ito S, Ohga T, Saeki H, Watanabe M, Kakeji Y, Morita M, Yamada T, Maehara Y.

Anticancer Res. 2007 Sep-Oct;27(5A):3345-53.

9.
10.

[Correlation of aberrant methylation of MGMT gene to MTHFR C677T genetic polymorphisms in esophageal squamous cell carcinoma].

Xue HC, Wang JM, Xu B, Guo GP, Hua ZL, Zhou Q, Zhu ZH, Ma ZK, Gao J.

Ai Zheng. 2008 Dec;27(12):1256-62. Chinese.

PMID:
19079989
11.
12.
13.

INK4a-ARF alterations and p53 mutations in primary and consecutive squamous cell carcinoma of the head and neck.

Weber A, Bellmann U, Bootz F, Wittekind C, Tannapfel A.

Virchows Arch. 2002 Aug;441(2):133-42. Epub 2002 Apr 4.

PMID:
12189502
14.

HPV-positive oropharyngeal squamous cell carcinoma is associated with TIMP3 and CADM1 promoter hypermethylation.

van Kempen PM, van Bockel L, Braunius WW, Moelans CB, van Olst M, de Jong R, Stegeman I, van Diest PJ, Grolman W, Willems SM.

Cancer Med. 2014 Oct;3(5):1185-96. doi: 10.1002/cam4.313. Epub 2014 Jul 26.

15.

p14ARF protein expression is a predictor of both relapse and survival in squamous cell carcinoma of the anterior tongue.

Kwong RA, Kalish LH, Nguyen TV, Kench JG, Bova RJ, Cole IE, Musgrove EA, Sutherland RL.

Clin Cancer Res. 2005 Jun 1;11(11):4107-16.

16.

Using Q-RT-PCR to measure cyclin D1, TS, TP, DPD, and Her-2/neu as predictors for response, survival, and recurrence in patients with esophageal squamous cell carcinoma following radiochemotherapy.

Brücher BL, Keller G, Werner M, Müller U, Lassmann S, Cabras AD, Fend F, Busch R, Stein H, Allescher HD, Molls M, Siewert JR, Höfler H, Specht K.

Int J Colorectal Dis. 2009 Jan;24(1):69-77. doi: 10.1007/s00384-008-0562-5. Epub 2008 Aug 13.

PMID:
18704459
17.
18.

Hypermethylation-modulated downregulation of RASSF1A expression is associated with the progression of esophageal cancer.

Mao WM, Li P, Zheng QQ, Wang CC, Ge MH, Hu FJ, Fang XH, Dong ZM, Ling ZQ.

Arch Med Res. 2011 Apr;42(3):182-8. doi: 10.1016/j.arcmed.2011.04.002.

PMID:
21722812
19.
20.

Prognostic significance of the deleted in colorectal cancer gene protein expression in high-risk resected gastric carcinoma.

Bamias AT, Bai MC, Agnantis NJ, Michael MC, Alamanos YP, Stefanaki SV, Razi ED, Skarlos DV, Kappas AM, Pavlidis NA.

Cancer Invest. 2003 Jun;21(3):333-40.

PMID:
12901278

Supplemental Content

Support Center